Trial intelligence / Profile preview

Perioperative dexmedetomidine to improve sleep quality in gynecologic patients

ChiCTR2500096752Phase 4Not yet recruiting

Sponsor
Linping District Women and Children Care Hospital
Start
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in sleep disorder (3 arms), sponsored by Linping District Women and Children Care Hospital. Primary endpoint: Sleep quality. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2500096752.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500096752.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call